Technical Analysis for NBTX - Nanobiotix S.A.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | 7.63% | |
| New 52 Week Low | Weakness | 7.63% | |
| Down 3 Days in a Row | Weakness | 7.63% | |
| Gapped Down | Weakness | 7.63% |
| Alert | Time |
|---|---|
| Rose Above 10 DMA | about 20 hours ago |
| Up 1 ATR | about 20 hours ago |
| Rose Above Previous Day's High | about 20 hours ago |
| 3x Volume Pace | about 20 hours ago |
| Outside Day | about 20 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/15/2024
Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell.
The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges.
Nanobiotix’s novel, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotix’s Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Immunotherapy Oncology Cancer Immunotherapy Virotherapy Immunotherapies Radiation Therapy Nanotechnology Nanomedicine Radiotherapy
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Immunotherapy Oncology Cancer Immunotherapy Virotherapy Immunotherapies Radiation Therapy Nanotechnology Nanomedicine Radiotherapy
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 8.962 |
| 52 Week Low | 3.5733 |
| Average Volume | 9,375 |
| 200-Day Moving Average | 5.63 |
| 50-Day Moving Average | 4.70 |
| 20-Day Moving Average | 4.21 |
| 10-Day Moving Average | 4.01 |
| Average True Range | 0.29 |
| RSI (14) | 43.50 |
| ADX | 19.82 |
| +DI | 21.25 |
| -DI | 23.09 |
| Chandelier Exit (Long, 3 ATRs) | 4.20 |
| Chandelier Exit (Short, 3 ATRs) | 4.44 |
| Upper Bollinger Bands | 4.76 |
| Lower Bollinger Band | 3.67 |
| Percent B (%b) | 0.37 |
| BandWidth | 25.70 |
| MACD Line | -0.25 |
| MACD Signal Line | -0.24 |
| MACD Histogram | -0.0061 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.87 | ||||
| Resistance 3 (R3) | 4.80 | 4.45 | 4.74 | ||
| Resistance 2 (R2) | 4.45 | 4.25 | 4.49 | 4.69 | |
| Resistance 1 (R1) | 4.26 | 4.12 | 4.36 | 4.34 | 4.65 |
| Pivot Point | 3.92 | 3.92 | 3.97 | 3.96 | 3.92 |
| Support 1 (S1) | 3.72 | 3.71 | 3.82 | 3.80 | 3.49 |
| Support 2 (S2) | 3.38 | 3.59 | 3.42 | 3.44 | |
| Support 3 (S3) | 3.19 | 3.38 | 3.40 | ||
| Support 4 (S4) | 3.26 |
